ULKER vs ECILC Comparison
Price, market cap, valuation, profitability and leverage metrics of ULKER and ECILC side by side.
If You Had Invested TRY 10,000
Metric Comparison
| Metric | ULKER | ECILC | Sector median |
|---|---|---|---|
| Last price (TL) | 85.45 | 63.90 | 10.76 |
| Daily change | −3.01% | −6.72% | −5.37% |
| Market cap | TRY 31.6B | TRY 43.8B | TRY 4.4B |
| P/E | 7.24 | — | 13.53 |
| P/B | 0.64 | 0.68 | 0.85 |
| Dividend yield | 5.17% | 2.04% | 1.23% |
| Return on equity | 9.85% | −3.08% | −0.82% |
| Free float | 44.47% | 22.02% | 32.02% |
Popular Comparisons
Related Pages
About the ULKER vs ECILC Comparison
Price, market cap, valuation multiples, profitability and leverage of ULKER (Ülker Bisküvi) and ECILC (Eczacıbaşı İlaç) side by side as of Sep 28, 2026, 15:47. Of the 16 metrics compared, ULKER leads in 11 and ECILC leads in 5.
Highlights: Daily change: ULKER leads (−3.01% vs −6.72%). Market cap: ECILC leads (TRY 43.8B vs TRY 31.6B). P/B: ULKER leads (0.64 vs 0.68). EV/EBITDA: ULKER leads (5.12 vs 165.19). EV/Sales: ULKER leads (1.18 vs 9.35). Dividend yield: ULKER leads (5.17% vs 2.04%). Gross margin: ECILC leads (37.83% vs 26.46%). EBITDA margin (annual): ULKER leads (18.03% vs 11.49%).
Frequently Asked Questions
Is ULKER or ECILC cheaper?
By P/E, Tie is cheaper (7.24 vs —); by P/B, ULKER trades at the lower multiple (0.64 vs 0.68).
Which is more profitable, ULKER or ECILC?
Annual net margin is 4.20% for ULKER and −20.86% for ECILC; return on equity is 9.85% for ULKER and −3.08% for ECILC.
Which is more leveraged, ULKER or ECILC?
The leverage ratio is 62.67 for ULKER and 18.92 for ECILC; net debt/EBITDA is 2.18 for ULKER and 1.37 for ECILC. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.